- Abstract Submission Deadline: January 06, 2026
- Pre Early Bird Registration Ends: January 08, 2026
Transforming your ideas into digital reality
Sed ut perspiciatis unde omnis natus error voluptatem santium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab nllo inventore veritatis quasi architecto beatae vitae
- Call Now
- Send Email
-
Address
8105 Rasor Blvd, Suite 112, Plano, TX 75024, USA
Cancer R&D 2026 Experts
Mark Pegram
Stanford University School of Medicine, CA
Raghu Kalluri
The University of Texas MD Anderson Cancer Center, TX
Dihua Yu
The University of Texas MD Anderson Cancer Center, TX
Michael B Yaffe
Massachusetts Institute of Technology, MA
Ken Chen
The University of Texas MD Anderson Cancer Center, TX
Ying-Chih Chang
CEO, Acrocyte Therapeutics Inc.
Taiwan
Keith T Wilson
Vanderbilt University Medical Center, TN
Stephen N Jones
Frederick National Laboratory for Cancer Research, National Institutes of Health, MD
Geeta Upadhyay
Uniformed Services University of the Health Sciences, MD
Stefanie Galban
University of Michigan
MI
David Alexander Potter
University of Minnesota
MN
Julie H Ostrander
University of Minnesota
MN
Peng Jiang
National Institutes of Health
MD
Qin Feng
University of Houston
TX
Yan Peng
University of Texas Southwestern Medical Center, TX
Ana M. Gamero
Lewis Katz School of Medicine at Temple University, PA
Dmitriy Minond
Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, FL
Sebastian Oltean
University of Exeter Medical School, United Kingdom
Mostafa Ibrahim
University of Michigan Medical School, MI
Mark B Reedy
Texas Tech University Health Sciences Center, TX
Jonathan T Busada
West Virginia University School of Medicine, WV